B-type natriuretic peptides and mortality after stroke: A systematic review and meta-analysisGARCIA-BERROCOSO, Teresa; GIRALT, Dolors; MONTANER, Joan et al.Neurology. 2013, Vol 81, Num 23, pp 1976-1985, issn 0028-3878, 10 p.Article

Fluorescent Molecular Peroxidation Products: A Prognostic Biomarker of Early Neurologic Deterioration After ThrombolysisLLOMBART, Víctor; DOMINGUEZ, Carmen; RIBO, Marc et al.Stroke (1970). 2014, Vol 45, Num 2, pp 432-437, issn 0039-2499, 6 p.Article

Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: The S100B/RAGE pathway : Translational ProteomicsMONTANE, Joan; MENDIOROZ, Maite; ROMERO, Francisco et al.Journal of proteomics (Print). 2012, Vol 75, Num 15, pp 4758-4765, issn 1874-3919, 8 p.Article

The Proteome of Human Brain After Ischemic StrokeCUADRADO, Eloy; ROSELL, Anna; MONTANER, Joan et al.Journal of neuropathology and experimental neurology. 2010, Vol 69, Num 11, pp 1105-1115, issn 0022-3069, 11 p.Article

Antibodies Preventing the Interaction of Tissue-Type Plasminogen Activator With N-Methyl-D-Aspartate Receptors Reduce Stroke Damages and Extend the Therapeutic Window of ThrombolysisMACREZ, Richard; OBIANG, Pauline; BEZIN, Laurent et al.Stroke (1970). 2011, Vol 42, Num 8, pp 2315-2322, issn 0039-2499, 8 p.Article